Serum Progesterone Concentration and Ongoing Pregnancy Rate in Frozen-Thawed Embryo Transfers with Intramuscular Plus Vaginal Progesterone Administration for Endometrial Preparation

Q4 Medicine
M. Mehrafza, A. Raoufi, Tahereh Zare Yousefi, Elmira Hosseinzadeh, Sajedeh Samadnia, Amirhossein Tamimi, A. Hosseini
{"title":"Serum Progesterone Concentration and Ongoing Pregnancy Rate in Frozen-Thawed Embryo Transfers with Intramuscular Plus Vaginal Progesterone Administration for Endometrial Preparation","authors":"M. Mehrafza, A. Raoufi, Tahereh Zare Yousefi, Elmira Hosseinzadeh, Sajedeh Samadnia, Amirhossein Tamimi, A. Hosseini","doi":"10.34172/jkmu.2022.74","DOIUrl":null,"url":null,"abstract":"Background: Insufficient serum progesterone level in the implantation phase may reduce the rate of pregnancy during freeze embryo transfer (FET) cycles. The present study aimed to evaluate the impact of FET day serum progesterone level on pregnancy outcomes in patients receiving intramuscular plus vaginal progesterone administration for endometrial preparation. Methods: Based on serum progesterone level on FET day, patients were divided into four quartiles: first (<25%), second (26–50%), third (51%–75%), and fourth (>75%). There was no significant difference among groups in basal characteristics. Results: No statistically significant difference was seen among groups concerning the mean number of retrieved and mature oocytes, embryos transferred, and endometrial thickness (EnT). The rate of implantation (P=0.5), biochemical (P=0.75), clinical (P=0.54), and ongoing pregnancy (P=0.5) were not associated with serum progesterone level on embryo transfer day. Conclusion: We found that there is no association between serum progesterone level on ET day and pregnancy outcome during FET cycles. It seems that combination therapy using intramuscular and vaginal progesterone, keeps the serum progesterone on ET day high enough that eliminates the need for serum progesterone measurement.","PeriodicalId":39002,"journal":{"name":"Journal of Kerman University of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Kerman University of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jkmu.2022.74","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Insufficient serum progesterone level in the implantation phase may reduce the rate of pregnancy during freeze embryo transfer (FET) cycles. The present study aimed to evaluate the impact of FET day serum progesterone level on pregnancy outcomes in patients receiving intramuscular plus vaginal progesterone administration for endometrial preparation. Methods: Based on serum progesterone level on FET day, patients were divided into four quartiles: first (<25%), second (26–50%), third (51%–75%), and fourth (>75%). There was no significant difference among groups in basal characteristics. Results: No statistically significant difference was seen among groups concerning the mean number of retrieved and mature oocytes, embryos transferred, and endometrial thickness (EnT). The rate of implantation (P=0.5), biochemical (P=0.75), clinical (P=0.54), and ongoing pregnancy (P=0.5) were not associated with serum progesterone level on embryo transfer day. Conclusion: We found that there is no association between serum progesterone level on ET day and pregnancy outcome during FET cycles. It seems that combination therapy using intramuscular and vaginal progesterone, keeps the serum progesterone on ET day high enough that eliminates the need for serum progesterone measurement.
冻融胚胎肌注加阴道黄体酮制备子宫内膜的血清黄体酮浓度和持续妊娠率
背景:着床期血清黄体酮水平不足可能降低冷冻胚胎移植(FET)周期的妊娠率。本研究旨在评估FET日血清黄体酮水平对肌注加阴道黄体酮子宫内膜准备患者妊娠结局的影响。方法:根据FET当天的血清孕酮水平,将患者分为4个四分位数:第一组(75%)。各组间基本特征无显著差异。结果:各组平均取卵数、成熟卵母细胞数、移植胚胎数、子宫内膜厚度差异无统计学意义。胚胎移植当日血清孕酮水平与着床率(P=0.5)、生化率(P=0.75)、临床率(P=0.54)、妊娠持续率(P=0.5)无相关性。结论:我们发现ET当天血清黄体酮水平与FET周期妊娠结局无相关性。肌肉注射和阴道孕酮的联合治疗似乎使ET当天的血清孕酮保持在足够高的水平,从而消除了血清孕酮测量的需要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信